Frankfurt - Delayed Quote EUR
Kura Oncology, Inc. (KUR.F)
5.85
+0.03
+(0.45%)
At close: June 11 at 8:07:52 AM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 13 | 13 | 13 | 14 |
| Avg. Estimate | 64.95M | 18.46M | 160.33M | 204M |
| Low Estimate | -- | -- | 19.31M | 20.05M |
| High Estimate | 375M | 102.7M | 438.6M | 451.2M |
| Year Ago Sales | -- | -- | 53.88M | 160.33M |
| Sales Growth (year/est) | 0.00% | 0.00% | 197.55% | 27.24% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| KUR.F | -- | -- | -- | -- |
| S&P 500 | 13.13% | 2.46% | 7.54% | 14.07% |
Upgrades & Downgrades
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 6/4/2025 |
| Maintains | Mizuho: Outperform to Outperform | 5/19/2025 |
| Maintains | Barclays: Overweight to Overweight | 5/2/2025 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 4/29/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/28/2025 |
| Maintains | UBS: Buy to Buy | 3/6/2025 |
Related Tickers
MLEC Moolec Science SA
7.05
+1.59%
SLGL Sol-Gel Technologies Ltd.
6.92
+0.14%
RPTX Repare Therapeutics Inc.
1.4400
-2.70%
BCYC Bicycle Therapeutics plc
8.76
+1.39%
ADVM Adverum Biotechnologies, Inc.
2.5900
-7.17%
STOK Stoke Therapeutics, Inc.
11.50
+1.23%
APVO Aptevo Therapeutics Inc.
4.6500
-0.43%
ADAP Adaptimmune Therapeutics plc
0.2722
-1.84%
SAGE Sage Therapeutics, Inc.
6.77
-3.15%
DNLI Denali Therapeutics Inc.
15.19
-0.46%